Skip to content

CorMedix CRMD Pre-Tax Income (Foreign)

Pre-Tax Income (Foreign) at other companies

TFX
TeleflexTFX
$16.25M-42.1%
Baxter International logo
Baxter InternationalBAX
$210M-30.6%
Medline, Inc.
 logo
Medline, Inc. MDLN

Other financials

Income statement

See full
Revenue$127.4M+226%
Gross profit$115.4M+207%
Operating income$63.7M+216%
Net income$38.6M+87.0%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total debt$4.3M+729%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$605.65M-34.4%
P/E3.4×
P/S1.5×-9.6×

Profitability

See full
Gross margin91.9%-3.5pp
Operating margin48.4%
Net margin45.2%
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%
Debt / equity0.0×
Current ratio-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign.

The official record: CorMedix’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's pre-tax income (foreign).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CorMedix's pre-tax income (foreign)?
CorMedix (CRMD) reported pre-tax income (foreign) of -$64.75K in Q4 2024.
How has CorMedix's pre-tax income (foreign) changed year-over-year?
CorMedix's pre-tax income (foreign) increased by 34.1% year-over-year, from -$98.3K to -$64.75K.
What is the long-term trend for CorMedix's pre-tax income (foreign)?
Over 2 years (2022 to 2024), CorMedix's pre-tax income (foreign) has grown at a -9.1% compound annual growth rate (CAGR), from -$313.56K to -$259K.
What does pre-tax income (foreign) mean?
The pre-tax earnings generated from international business operations, excluding discontinued operations and extraordinary items. This metric highlights the profitability and market penetration of the company's global footprint. It allows investors to assess the impact of foreign economic conditions and currency fluctuations on the company's overall bottom line.